252 related articles for article (PubMed ID: 7342853)
1. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
Phelan ET; Vietti TJ; Valeriote FA; Coulter D
Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
Presant CA; Vietti T; Valeriote F
Cancer Res; 1975 Aug; 35(8):1926-30. PubMed ID: 50128
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of cytosine arabinoside and thiopurines.
Valeriote F; Vietti T; Edelstein M
Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
[TBL] [Abstract][Full Text] [Related]
4. Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice.
Presant CA; Coulter D; Valeriote F; Vietti TJ
J Natl Cancer Inst; 1981 Jun; 66(6):1151-4. PubMed ID: 6165854
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
Vietti TJ; Valeriote FA; Kalish R; Coulter D
Cancer Treat Rep; 1978 Sep; 62(9):1313-20. PubMed ID: 688275
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
Maki PA; Sladek NE
Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
[TBL] [Abstract][Full Text] [Related]
7. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
Santelli G; Valeriote F
J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
Paprocka M; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(3):285-91. PubMed ID: 3592932
[TBL] [Abstract][Full Text] [Related]
9. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
Presant CA; Valeriote F; Vietti TJ
Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
[TBL] [Abstract][Full Text] [Related]
10. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
Razek A; Vietti T; Valeriote F
Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
[No Abstract] [Full Text] [Related]
11. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
Pazdernik TL; Uyeki EM
J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Jiang R; Bony V; Lopez M
Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
[No Abstract] [Full Text] [Related]
13. Effect of cyclophosphamide on mouse bone marrow and leukemic stem cells.
Paprocka M; Budzyński W; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1980; 28(3):447-51. PubMed ID: 7447649
[TBL] [Abstract][Full Text] [Related]
14. Effects of oxazaphosphorine cytostatics on granuloid progenitor cell (CFUc) proliferation in mice.
Semont H; Hecquet C; Adolphe M; Deysson G
Exp Hematol; 1982 Oct; 10(9):782-8. PubMed ID: 7173344
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
Jones RJ; Colvin OM; Sensenbrenner LL
Cancer Res; 1988 Jun; 48(12):3394-7. PubMed ID: 3285994
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor and immunodepressive action of dexamethasone on a leukemia L-1210 model].
Berezina TA; Uteshev BS; Babichev VS
Farmakol Toksikol; 1979; 42(5):537-41. PubMed ID: 488332
[TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent cytotoxicity of 5-fluorouracil in mice.
Santelli G; Valeriote F
J Natl Cancer Inst; 1986 Jan; 76(1):159-64. PubMed ID: 3455738
[TBL] [Abstract][Full Text] [Related]
18. Interaction of cimetidine but not ranitidine with cyclophosphamide in mice.
Dorr RT; Soble MJ; Alberts DS
Cancer Res; 1986 Apr; 46(4 Pt 1):1795-9. PubMed ID: 3948164
[TBL] [Abstract][Full Text] [Related]
19. alpha-Tocopherol pretreatment increases adriamycin bone marrow toxicity.
Alberts DS; Peng YM; Moon TE
Biomedicine; 1978 Oct; 29(6):189-91. PubMed ID: 737277
[TBL] [Abstract][Full Text] [Related]
20. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
